Captopril suppression: Limitations for confirmation of primary aldosteronism

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 12, Issue 3, 2011, Pages 326-332

  Westerdahl, Christina ^a   Bergenfelz, Anders ^a   Isaksson, Anders ^a   Valdemarsson, Stig ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Aldosterone; captopril; hypertension; primary aldosteronism; renin

Indexed keywords

ALDOSTERONE; CAPTOPRIL;

ADULT; AGED; ALDOSTERONE RENIN RATION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIMARY HYPERALDOSTERONISM; RENAL SYSTEM PARAMETERS; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; FEMALE; HEALTH; HUMANS; HYPERALDOSTERONISM; MALE; RENIN; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 80052380853     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320310390405     Document Type: Article

References (32)

1. Stowasser M. and Gordon RD Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 2003 ; 17: 591-605.
2. Young WF Jr. Mini review: Primary aldosteronism- changing concepts in diagnosis and treatment. Endocrinology 2003 ; 144: 2208-2213. (Pubitemid 36629868)
3. Funder JW, Carey RM, Fardella C., Gomez-Sanchez CE, Mantero F., Stowasser M. et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An Endocrine Society Clinical Practice Guidline. JCEM 2008 ; 93 ; 3266-3281.
4. Nadar S., Lip GY and Beevers DG Primary hyperaldosteronism. Ann Clin Biochem. 2003 ; 40: 439-452. (Pubitemid 37152197)
5. Conn JW Presidential address: Part1. Painting background, Part II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955 ; 45: 3-15.
6. Gordon RD, Klemm SA, Stowasser M., Tunny TJ, Storie WJ and Rutherford JC How common is primary aldosteronism? Is it the most frequent form of curable hypertension? J Hypertens 1993 ; 11: S310 - S311. (Pubitemid 24024823)
7. Lim PO, Rodgers P., Cardale K., Watson AD and MacDonald TM Potentially high prevalence of primary aldosteronism in a primary care population. Lancet 1999 ; 353: 40. (Pubitemid 29037708)
8. Mulatero P., Stowasser M., Loh KC, Fardella CE, Gordon RD, Mosso L. et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centres from five continents. J Clin Endocrinol Metab 2004 ; 89: 1045-1050. (Pubitemid 38368386)
9. Bencherit S., Bernheim J. and Podjarny E. Normokalemic hyperaldosteronism in patients with resistant hypertension. Israel Med Assoc J 2002 ; 4: 17-20.
10. Westerdahl C., Bergenfelz A., Isaksson A., Wihl A., Nerbrand C. and Valdemarsson S. High frequency of primary aldosteronism among hypertensive patients from a primary care area in Sweden. Scand J Prim Health Care 2006 ; 24: 154-159. (Pubitemid 44272851)
11. Perschel FH, Schemer R., Seiler L., Reincke M., Deinum J. and Maser-Gluth C. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays. Clin Chem 2004 ; 50: 1650-1655. (Pubitemid 39121234)
12. Cartledge S. and Lawson N. Aldosterone and renin measurements. Ann Clin Biochem 2000 ; 37: 262-278. (Pubitemid 30242756)
13. Unger N., Lopez Schmidt I., Pitt C., Walz MK, Philipp T., Mann K., et al. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol 2004 ; 150: 517-523. (Pubitemid 38584703)
14. Montori VM and Young WF Jr. Use of plasma aldosterone concenteration- to plasma renin activity ratio as a screening test for primary aldosteronism. A systemic review of the literature. Endocrinol Metab Clin North Am 2002 ; 31: 619-632. (Pubitemid 35006613)
15. Giacchetti G., Ronoconi V., Lucarelli G., Boscaro M. and Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: Need for a standardized protocol. J Hypertens 2006 ; 24: 737-745.
16. Hiramatsu K., Yamada T. and Yukimara Y. A screening test to identify aldosterone- producing adenomas by measuring plasma renin activity. Results in hypertensive patients. Arch Int Med 1981 ; 141: 1589-1593. (Pubitemid 12234064)
17. Westerdahl C., Bergenfelz B., Larsson J., Nerbrand C., Valdemarsson S., Wihl A. et al. Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone. Scand J Clin Lab Invest 2008 ; 24: 1-8.
18. Lyons DF, Kem DC, Brown RD, Hansson CS and Carollo MI Single dose captopril as a diagnosic test for primary aldosteronism. J Clin Endocrinol Metab 1983 ; 57: 892-896. (Pubitemid 14204282)
19. Stowasser M., Gordon RD, Rutherford JC, Nikwan NZ, Daunt N. and Slater GJ Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001 ; 2: 156-169. (Pubitemid 33685887)
20. Young W. F Primary aldosteronism: Renaissance of a syndrome. Clin Endocrinol 2007 ; 66: 607-618. (Pubitemid 46699525)
21. Rossi GP, Belfiore A., Bernini G., Desideri G. et al. Comparison of the Captopril and the saline infusion test for excluding aldosterone -producing adenoma. Hypertension 2007 ; 50: 424-431. (Pubitemid 47205795)
22. Agharzii M., Douville P., Grose J. et al. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 2001 ; 37: 1440-1443.
23. Castro O., Yu X. and Kern D. Diagnostic value of the post Captopril test in primary aldosteronism. Hypertension 2002 ; 39: 935-938. (Pubitemid 34437553)
24. Rossi E., Regolisti G., Negro A., Sani C., Davoli S. and Perazzoli F. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to plasma renin ratio as a screening test among Italian hypertensives. Am J Hyperten 2002 ; 15: 896-902. (Pubitemid 35168429)
25. Ahokoski O., Virtanen A., Kariristo V., Scheinin H., Huupponen R. and Irjala K. Biological day-to-day variation and reference change limits of serum cortisol and aldosterone in healthy young men on unrestricted diets. Clin Chem 1999 ; 45: 1097-1099. (Pubitemid 29340553)
26. Conell J., Scott M. MacKenzie E., Freel M., Fraser R. and Davis E. A lifetime of aldosterone excess: Long term consequences of altered regulation of aldosterone production for cardiovascular function. Endocrine Reviews 2008 ; 29: 133-154. (Pubitemid 351519688)
27. Mulatero P., Bertello C., Garrone C., Rossato D., Mengozzi G., Verhovez A. et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hyperpension 2007 ; 50: e26 - e27. (Pubitemid 47205812)
28. Padfield PL, Brown JJ, Davies D., Fraser R., Lever AF, Morton JJ et al. The myth of idiopathic hyperaldosteronism. Lancet 1981 2: 83-84 ; (Pubitemid 11069879)
29. Mantero F., Fallo F., Opocher G., Armanini D. and Boscaro M., Scaroni C. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Clin Sci (Lond) 1981 ; 61: 289s - 293s. (Pubitemid 12222752)
30. Hambling C., Jung RT, Gunn A., Browning MC and Bartlett WA Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin Endocrinol (Oxf) 1988 ; 36: 499-503.
31. Mantero F., Bedeno O. and Opocher G. Does dynamic testing have a place in the modern assessment of endocrine hypertension? J Renin Angiotensin Aldosterone Syst 2001 ; 2: 156-169.
32. Naomi S., Iwaoka T., Umeda T., Inoue J., Hamasaki S., Miura F. et al. Clinical evaluation of the captopril screening test for primary aldosteronism. Jpn Heart J 1985 ; 26: 549-556. (Pubitemid 15013099)